Top of this page
Skip navigation, go straight to the content

Newsroom Press Releases

Transparency notifications

Brussels (Belgium), 7 November 2016 – 23:00 (CEST) – regulated information

1. Summary of the notifications

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency notifications from BlackRock, Inc. (having its registered offices at 55 East 52nd Street, New York, NY, 10055, U.S.A.), dated 2 and 3 November 2016 respectively.

In the first notification, BlackRock, Inc. informed that, following a disposal of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV had decreased and had crossed downward the 3% threshold on 31 October 2016. In the second notification, BlackRock, Inc. notified that it crossed the 3% minimum threshold again, following an acquisition of UCB shares with voting rights by its affiliates on 1 November 2016.

On 31 October 2016, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 780 148 UCB shares with voting rights (versus 5 964 748 UCB shares in its previous notification dated 4 December 2015), representing 2.97% of the total number of shares issued by the company (194 505 658) (versus 3.07% on 4 December 2015).

On 1 November 2016, BlackRock, Inc. (taking into account the holding of its affiliates) announced that it owned 6 030 756 UCB shares with voting rights, representing 3.10% of the total number of shares issued by the company.

2. Content of the notifications

The transparency notification dated 2 November 2016 included the following information:

  • Date on which the threshold is crossed: 31 October 2016.
  • Threshold crossed (in %): 3%.
  • Persons subject to the notification requirement:

  • Notified details:

  • Additional information: The disclosure obligation arose due to voting rights for BlackRock, Inc. going below 3% in heading 10) A).

The transparency notification dated 3 November 2016 included the following information:

  • Date on which the threshold is crossed: 1 November 2016.
  • Threshold crossed (in %): 3%.
  • Persons subject to the notification requirement:

  • Notified Details:

  • Additional information: The disclosure obligation arose due to voting rights for BlackRock, Inc. going above 3% in heading 10) A).

The information mentioned hereafter was identical in both notifications:

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights.
  • Notification by: A parent undertaking or a controlling person.

 

  •  Denominator: 194 505 658.
  • Chain of controlled undertakings through which the holding is effectively held:

Please see the full chain of control in the PDF separately attached to these notifications.

3. Further information

This press release and the detailed transparency notifications are available on UCB SA/NV’s website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be included in the corporate governance charter of UCB SA/NV, which is available on its website via the following link.

Antje Witte         
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
 Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com  

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 3.9 billion in 2015. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news

 


Stay up-to-date on the latest news and information from UCB